Gene therapy startup targets ‘aging itself’ to combat blinding disease

Cirrus Therapeutics lands seed funding to advance gene therapy designed to prevent and reverse dry AMD by rejuvenating the retina. Ophthalmology focused biotech Cirrus Therapeutics has raised $11 million in seed financing to advance a gene therapy program that targets the underlying biology of dry age-related macular degeneration (AMD), one of the leading causes of […] The post Gene therapy startup targets ‘aging itself’ to combat blinding disease appeared first on Longevity.Technology.